Proteinuria in Liver Transplantation, a Single Egyptian Center Study
NCT ID: NCT05733754
Last Updated: 2023-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2023-03-31
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
NCT06924294
Haemostatic Imbalance in Patients With Chronic Liver Disease
NCT03589430
Evaluation of Hepatic Affection in Hemodialysis Patients With Iron Overload in Assiut University Hospital
NCT05028595
Validity of Mini Fluid Challenge Post Liver Transplantation
NCT03396159
Acute Liver Injury in Patients With Pneumonia
NCT06103981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In spite of the fact that proteinuria has been increasingly considered as a significant manifestation of acute or chronic renal disease , no study clarify the association between presence of proteinuria and prognosis of patients undergoing liver transplant.
The aim of the study
Primary objective:
Assess proteinuria as an early marker of renal dysfunction for liver transplant.
Secondary objective:
Defining different risk factors causing proteinuria.
Patients and methods
1. Study design Retrospective study
2. Inclusion criteria A total of 70 patients with end-stage liver disease received liver transplant will be included.
3. Exclusion criteria
* Patients less than 18 years of age.
* Patients with end-stage renal disease.
All data of patients will include :
* Demographic information, etiologies of primary liver disease, clinical parameters, lab investigations including CBC, urea, creatinine, liver enzymes, hepatitis viral markers, CMV infection, lipid profile, fasting and 2hours post prandial glucose level, anesthesia time, operation time, duration of hospitalization and ICU stay, and outcome.
* Associated medical conditions as diabetes mellitus, hypertension, dyslipidemia .
* The urinary analysis before transplantation and follow up for 6 months if proteinuria is present .
* types of immunosuppression taken.
* Occurrence of dialysis (temporary)
* Severity of liver disease will be assessed by CP points and MELD score Statistical analysis
1. An excel sheet well be performed for data collection
2. Clinical and laboratory data will be statistically analyzed
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with end-stage renal disease.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa M.Abokresha
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
marwa m abokrsha, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturerer of internal medicine Gastroenterology and hepatology
Ramy A Hassan, Md
Role: STUDY_CHAIR
Assistant professor of surgery
Ahmed m Taha, MD
Role: STUDY_CHAIR
Assistant professor of surgery
Lobna A Ahmed, MD
Role: PRINCIPAL_INVESTIGATOR
Professor of internal medicine Gastroenterology and hepatology
Reem E Mahdy, MD
Role: PRINCIPAL_INVESTIGATOR
Consultant of internal medicine and hepatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Glassock RJ. Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep. 2010 Oct;12(5):364-8. doi: 10.1007/s11906-010-0133-3.
Heller F, Frischmann S, Grunbaum M, Zidek W, Westhoff TH. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol. 2011 Oct;6(10):2347-55. doi: 10.2215/CJN.02490311. Epub 2011 Sep 1.
Huang TM, Wu VC, Young GH, Lin YF, Shiao CC, Wu PC, Li WY, Yu HY, Hu FC, Lin JW, Chen YS, Lin YH, Wang SS, Hsu RB, Chang FC, Chou NK, Chu TS, Yeh YC, Tsai PR, Huang JW, Lin SL, Chen YM, Ko WJ, Wu KD; National Taiwan University Hospital Study Group of Acute Renal Failure. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol. 2011 Jan;22(1):156-63. doi: 10.1681/ASN.2010050553. Epub 2010 Nov 29.
Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology. 2001 Aug;34(2):255-61. doi: 10.1053/jhep.2001.26522.
Cholongitas E, Senzolo M, Patch D, Shaw S, Hui C, Burroughs AK. Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther. 2006 Aug 1;24(3):453-64. doi: 10.1111/j.1365-2036.2006.02998.x.
Pan HC, Jenq CC, Tsai MH, Fan PC, Chang CH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA). Aliment Pharmacol Ther. 2014 Nov;40(9):1056-65. doi: 10.1111/apt.12953. Epub 2014 Sep 11.
Wong CS, Lee WC, Jenq CC, Tian YC, Chang MY, Lin CY, Fang JT, Yang CW, Tsai MH, Shih HC, Chen YC. Scoring short-term mortality after liver transplantation. Liver Transpl. 2010 Feb;16(2):138-46. doi: 10.1002/lt.21969.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Proteinuria
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.